4/A//SEC Filing
SAVIENT PHARMACEUTICALS INC 4/A
Accession 0000950117-09-000241
CIK 0000722104operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 12:01 PM ET
Size
11.8 KB
Accession
0000950117-09-000241
Insider Transaction Report
Form 4/AAmended
Hamelin Paul
President
Transactions
- Sale
Common Stock, $.01 par value per share
2009-02-17$5.77/sh−1,777$10,252→ 97,034 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2009-02-19$8.27/sh+40,000$330,800→ 140,000 totalExercise: $8.27From: 2009-02-19Exp: 2009-02-19→ Common Stock, $.01 par value per share (40,000 underlying) - Award
Common Stock, $.01 par value per share
2009-02-13$5.94/sh+50,000$297,000→ 98,811 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2009-02-19$5.27/sh+100,000$527,000→ 100,000 totalExercise: $5.27From: 2010-02-19Exp: 2018-02-19→ Common Stock, $.01 par value per share (100,000 underlying)
Footnotes (4)
- [F1]The right to receive these shares is pursuant to a restricted stock grant and such shares issue and vest as to 33.3% on each of 2/13/10, 2/13/11 and 2/13/12, provided the grantee remains employed by the Company on these dates.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.
- [F3]The number of derivative securities listed as acquired was inadvertently previously reported as disposed in a filing on February 19, 2009.
- [F4]These options will become exercisable as to 25% on each of 2/19/10, 2/19/11, 2/19/12 and 2/19/13, provided the optionee remains employed by the Company on these dates.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 12:01 PM ET
- Size
- 11.8 KB